Boston Scientific Reports 3Q Revenue of $5.14B, Net Income of $582M
Third-quarter revenue rose 1.4% year over year, while net income fell 22.9% to $582M and diluted EPS declined 21.6% to $0.4. The company said an August cybersecurity incident disrupted manufacturing, order processing and shipments, weighing on results.
Boston Scientific reported third-quarter 2026 revenue of $5.14B, up 1.4% from the prior-year quarter, while net income fell 22.9% to $582M and diluted EPS declined 21.6% to $0.4. An August cybersecurity incident disrupted manufacturing, order processing and shipments, weighing on quarterly results…